Background and Objective: Cancer of the pancreas constitutes one of the major causes of cancer related death throughout the world. A 5-year survival rate of only 2% and a maximum of 20 months median survival in multi modality treatment studies dealing with the most favorable patients only, has been
Experimental pancreatic cancer in the rat treated by photodynamic therapy
✍ Scribed by Dr S. Evrard; P. Keller; A. Hajri; G. Balboni; L. Mendoza-Burgos; C. Damgé; J. Marescaux; M. Aprahamian
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 597 KB
- Volume
- 81
- Category
- Article
- ISSN
- 0007-1323
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Background and Objectives: C6-ceramide analog LCL29 was recently shown to improve the cure rates of mouse tumors treated by photodynamic therapy (PDT), but the mechanism underlying the therapeutic gain remains unclear. Since LCL29 is a pro-apoptotic agent, the main objective of the present study was
## Background and objective: We previously demonstrated that a hydrophilic photosensitizer atx-s10 had a potent photodynamic effect. this study was designed to reveal the long-term effectiveness of photodynamic therapy (pdt) with this agent in occluding choroidal neovascularization (cnv) and its se
Photodynamic therapy (PDT) is a promising approach to the treatment of cancer. Preferential retention of the photosensitizer by malignant tissue has been considered a hallmark of this treatment modality. However, photosensitivity can be observed in normal, non-neoplastic tissues, and the present stu
## Abstract Fifty-five patients with locally advanced breast cancer treated with initial endocrine therapy have been followed up for periods of between 6 and 64 months (median 17 months) with regular clinical and radiological examination. The aim of the study was to evaluate the role of mammography